hiv reverse transcriptase

navigate by keyword : aids anti binding catalytic dna enzyme heterodimeric hiv hiv1 immunodeficiency inactivation inhibitor molecule multiplication non nucleoside nucleotide protein retrovirus reverse rna site therapy transcriptase transcription virus

Emtricitabine molecule 3D illustration. Royalty Free Stock Photo

HIV Virus Reverse Transcriptase Block Royalty Free Stock Photo

HIV-1 reverse transcriptase enzyme Royalty Free Stock Photo

Etravirine HIV drug molecule Non-nucleoside reverse transcriptase inhibitor. Skeletal formula. Royalty Free Stock Photo

Stavudine d4T HIV drug molecule. Thymidine analog that blocks reverse-transcriptase. Royalty Free Stock Photo

Doravirine HIV drug molecule non-nucleoside reverse transcriptase inhibitor. Skeletal formula. Royalty Free Stock Photo

Stavudine d4T HIV drug molecule. Thymidine analog that blocks reverse-transcriptase. Skeletal formula. Royalty Free Stock Photo

Etravirine HIV drug molecule (Non-nucleoside reverse transcriptase inhibitor). Atoms are represented as spheres with conventional Royalty Free Stock Photo

Doravirine HIV drug molecule (non-nucleoside reverse transcriptase inhibitor). 3D rendering. Atoms are represented as spheres with Royalty Free Stock Photo

Doravirine HIV drug molecule (non-nucleoside reverse transcriptase inhibitor Royalty Free Stock Photo

The human immunodeficiency virus single-stranded RNA genome is converted into double-stranded DNA by the viral reverse transcriptase and then the DNA is integrated in the DNA of an infected human cell. The reverse transcriptase is one of the main targets to disrupt the virus multiplication through an inhibitor. There are nucleoside and nucleotide inhibitors and non nucleoside analogue inhibitors.